UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $17

Benzinga · 3d ago
UBS analyst Jay Sole maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $19 to $17.